Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, recently announced it has completed its acquisition of Ambry Genetics, a ...
Delving into the details, we found 42% of traders were bullish, while 53% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $148,440, and 24 were calls, valued ...
Zacks Investment Research on MSN4h
Should You Buy, Sell or Hold BBAI Stock at Its P/S of 11.29X?Bigbear.ai’s BBAI shares are currently overvalued, as suggested by its Value Score of F. In terms of the forward 12-month price/sales (P/S), BBAI is trading at 11.29X, significantly higher than its ...
BigBear.ai (BBAI), a provider of artificial intelligence (AI)-powered decision intelligence solutions, has recently scored ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, recently announced it has completed its acquisition of Ambry Genetics, a ...
BigBear.ai is making waves with AI-driven tools for decision-making in defense and complex industries. Read why I'm neutral ...
Zacks Investment Research on MSN22h
BigBear.ai Holdings, Inc. (BBAI) Laps the Stock Market: Here's WhyBigBear.ai Holdings, Inc. (BBAI) closed at $8.72 in the latest trading session, marking a +1.51% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.67% for the day.
The stock saw big gains last week connected to new contract wins. Tech leaders and government officials participated in an AI ...
BigBear.ai Holdings, Inc. is similar to Palantir but lacks profitability and a compelling product portfolio, making it a ...
In the fast-paced world of investing, staying ahead requires good ideas and timely decisions. This article highlights five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback